LINC02287

Across TCGA pan-cancer cohorts, LINC02287 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC02287 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02287 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02287 expression acts as an unfavorable survival marker, although some lineages such as PAAD show a favorable association.

COAD, ACC, and LIHC are the cancer types where LINC02287 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	IV	0.295	0.551	.003	121	view →
ACC	DFS	Tertile	All	0.175	0.717	<.001	90	view →
LIHC	OS	Tertile	All	0.658	0.830	<.001	49	view →
READ	OS	Tertile	IV	0.200	0.927	<.001	48	view →
PAAD	OS	Quartile	All	0.649	0.310	.003	20	view →
KIRC	OS	Quartile	All	0.521	0.674	.003	20	view →
LAML	DFS	Quartile	All	0.271	0.581	.002	16	view →
PRAD	OS	Tertile	All	0.962	0.997	.003	10	view →
SKCM	OS	Quartile	All	0.246	0.421	.025	6	view →
MESO	OS	Tertile	All	0.289	0.437	.036	6	view →
HNSC	OS	Quartile	All	0.702	0.787	.044	3	view →
ESCA	OS	Median	II,III,IV	0.390	0.566	.037	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC02287–COAD (DFS)

Open the COAD breakdown →